These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6468028)

  • 21. [Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans].
    Chmelar D; Vrtný J
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):97-102. PubMed ID: 20640988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriocin typing of Enterobacter cloacae strains (author's transl)].
    Freitag V; Friedrich O
    Zentralbl Bakteriol A; 1981 Mar; 249(1):63-75. PubMed ID: 7023122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility.
    Silva JO; Martins Reis AC; Quesada-Gómez C; Pinheiro AQ; Freire RS; Oriá RB; de Carvalho CB
    Anaerobe; 2014 Aug; 28():24-8. PubMed ID: 24799339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of Bacteroides fragilis serotypes amongst clinical strains.
    Elhag KM; Tabaqchali S
    J Hyg (Lond); 1978 Aug; 81(1):89-97. PubMed ID: 690426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production.
    Govan JR; Harris G
    J Clin Microbiol; 1985 Oct; 22(4):490-4. PubMed ID: 4077961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriocin formation and bacteriocin sensitivity in Bacterioides fragilis and Bacterioides thetaiotaomicron from clinical material].
    Podhaisky C; Reinhold L
    Zentralbl Bakteriol Orig; 1970; 215(4):475-82. PubMed ID: 4925378
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitor production by group-G streptococci of human and of animal origin.
    Tagg JR; Wong HK
    J Med Microbiol; 1983 Nov; 16(4):409-15. PubMed ID: 6644786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and purification of bacteriocin from Prevotella intermedia (Bacteroides intermedius).
    Takada K; Hirasawa M; Ikeda T
    J Periodontol; 1991 Jul; 62(7):439-44. PubMed ID: 1920011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriocin production by strains of Bacteroides isolated from human feces and the role of these strains in the bacterial ecology of the colon.
    Booth SJ; Johnson JL; Wilkins TD
    Antimicrob Agents Chemother; 1977 Apr; 11(4):718-24. PubMed ID: 856024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of enterotoxigenic Bacteroides fragilis (ETBF), among strains isolated between 1976 and 1995 in Poland.
    Meisel-Mikołajczyk F; Pituch H; Rouyan GS
    Acta Microbiol Pol; 1996; 45(2):187-92. PubMed ID: 8997696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.
    Tong J; Liu C; Summanen P; Xu H; Finegold SM
    Anaerobe; 2011 Apr; 17(2):64-8. PubMed ID: 21439390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation of anaerobic bacteria from clinical specimens and the drug susceptibility of Bacteroides fragilis].
    Ho SW; Hsien WC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):8-13. PubMed ID: 578133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different methods for bacteriocin typing of Klebsiella strains.
    Simoons-Smit AM; Verweij-van Vught AM; Kanis IY; Maclaren DM
    J Hyg (Lond); 1983 Jun; 90(3):461-73. PubMed ID: 6345661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochemical evidence for multiple serotypes of Bacteroides fragilis.
    Cherniak R; Lombard GL; Dowell VR
    J Clin Microbiol; 1979 Jun; 9(6):699-704. PubMed ID: 91622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple method for detecting Bacteroides spp. bacteriocin production.
    Riley TV; Mee BJ
    J Clin Microbiol; 1981 Mar; 13(3):594-5. PubMed ID: 7016904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the biomed bacteroides IF kit for identification of Bacteroides fragilis group strains.
    Vege A; Hofstad T; Sawicka-Grzelak A; Pituch H; Meisel-Mikolajczyk F
    Eur J Clin Microbiol; 1986 Aug; 5(4):464-5. PubMed ID: 3530752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.